118 related articles for article (PubMed ID: 19615744)
1. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome.
Hussein K; Theophile K; Büsche G; Schlegelberger B; Göhring G; Kreipe H; Bock O
Leuk Res; 2010 Mar; 34(3):328-34. PubMed ID: 19615744
[TBL] [Abstract][Full Text] [Related]
2. Aberrant microRNA expression pattern in myelodysplastic bone marrow cells.
Hussein K; Theophile K; Büsche G; Schlegelberger B; Göhring G; Kreipe H; Bock O
Leuk Res; 2010 Sep; 34(9):1169-74. PubMed ID: 20627384
[TBL] [Abstract][Full Text] [Related]
3. c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development.
Lin YC; Kuo MW; Yu J; Kuo HH; Lin RJ; Lo WL; Yu AL
Mol Biol Evol; 2008 Oct; 25(10):2189-98. PubMed ID: 18667440
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia.
Gao XN; Lin J; Gao L; Li YH; Wang LL; Yu L
Leuk Res; 2011 Sep; 35(9):1226-32. PubMed ID: 21724256
[TBL] [Abstract][Full Text] [Related]
5. [Expression of cell cycle control genes in myelodysplastic syndromes].
Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Cao YR; Wang XL; Tu MF
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):10-4. PubMed ID: 15946501
[TBL] [Abstract][Full Text] [Related]
6. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-dependent regulation of cKit in cutaneous melanoma.
Igoucheva O; Alexeev V
Biochem Biophys Res Commun; 2009 Feb; 379(3):790-4. PubMed ID: 19126397
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
10. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome.
de Melo Campos P; Traina F; da Silva Santos Duarte A; Lorand-Metze I; Costa FF; Saad ST
Leuk Res; 2007 Jun; 31(6):853-7. PubMed ID: 17270269
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of delta-like (Dlk) in a subset of myelodysplastic syndrome bone marrow trephines.
Länger F; Stickel J; Tessema M; Kreipe H; Lehmann U
Leuk Res; 2004 Oct; 28(10):1081-3. PubMed ID: 15289021
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes.
Shao Z; Zhang H; Chen G; Wang L; Li K; Zhang Y; Li L; Sun J
Chin Med J (Engl); 2001 May; 114(5):481-5. PubMed ID: 11780408
[TBL] [Abstract][Full Text] [Related]
15. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
Nimer SD
J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
[TBL] [Abstract][Full Text] [Related]
17. Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia.
Mahadevan D; DiMento J; Croce KD; Riley C; George B; Fuchs D; Mathews T; Wilson C; Lobell M
Am J Hematol; 2006 Oct; 81(10):779-86. PubMed ID: 16838325
[TBL] [Abstract][Full Text] [Related]
18. [Study of the expression and function of c-kit receptor on the bone marrow mononuclear cells of the patients with myelodysplastic syndromes].
Zhang H; Shao Z; Chen G; Wang L; Zhang Y; Li K; Li L; Sun J; Hao Y
Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):176-8. PubMed ID: 11876975
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes.
Vasilatou D; Papageorgiou SG; Kontsioti F; Kontos CK; Tsiotra P; Mpakou V; Pavlou MA; Economopoulou C; Dimitriadis G; Dervenoulas J; Pappa V
Leuk Res; 2013 Mar; 37(3):251-8. PubMed ID: 23246221
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
